Doyle Wealth Management Regeneron Pharmaceuticals, Inc. Transaction History

Doyle Wealth Management

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 05, 2019	SELL	$273.46 - $318.39 $54,691 - $63,678	-200 Closed	0 $0
Q2 2019 Aug 15, 2019	BUY	$299.6 - $414.82 $59,920 - $82,964	200 New	200 $63,000
Q1 2019 May 13, 2019	SELL	$372.08 - $439.57 $65,114 - $76,924	-175 Closed	0 $0
Q4 2018 Feb 08, 2019	BUY	$335.82 - $403.04 $58,768 - $70,532	175 New	175 $65,000

1,534

83.6M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.7B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Doyle Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Doyle Wealth Management with notifications on news.